stock.name

Intra-Cellular Therapies Inc

ITCI

Market Cap$6.62B
Close$

Compare Intra-Cellular Therapies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Intra-Cellular Therapies IncIntra-Cellular Therapies Inc00%---
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$70.24

Current Fair Value

1.5% upside

Undervalued by 1.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.62 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Beta0.82
Outstanding Shares96,807,191
Avg 30 Day Volume772,670

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

ESG Score

No data

About Intra-Cellular Therapies Inc

CEO: Sharon Mates